{ "cik": 1070494, "cik_padded": "0001070494", "entityName": "ACADIA PHARMACEUTICALS INC", "fiscal_years": [ { "accn": "0001193125-26-072519", "filed": "2026-02-26", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 4690000.0, "cash": 177695000.0, "eps_diluted": 2.3, "free_cash_flow": 105146000.0, "net_income": 391000000.0, "operating_cash_flow": 109836000.0, "operating_income": 104811000.0, "revenue": 1071505000.0, "stockholders_equity": 1227390000.0, "total_assets": 1564195000.0, "total_liabilities": 336805000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.27440748254426056, "net_margin": 0.3649073032790328, "operating_margin": 0.09781662241426778, "revenue_growth_yoy": 0.11871826702317924, "roa_avg2y": 0.2841620363153268, "roa_period_end": 0.24996883380908388, "roe_avg2y": 0.3989423436485267, "roe_period_end": 0.3185621522091593 } }, { "accn": "0001193125-26-072519", "filed": "2026-02-26", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 523000.0, "cash": 319589000.0, "eps_diluted": 1.36, "free_cash_flow": 157196000.0, "net_income": 226451000.0, "operating_cash_flow": 157719000.0, "operating_income": 230794000.0, "revenue": 957797000.0, "stockholders_equity": 732793000.0, "total_assets": 1187756000.0, "total_liabilities": 454963000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.6208615529897256, "net_margin": 0.2364290136636469, "operating_margin": 0.24096337741713536, "revenue_growth_yoy": 0.31848598020199964, "roa_avg2y": 0.2338509804245546, "roa_period_end": 0.1906544778557212, "roe_avg2y": 0.3889079711613433, "roe_period_end": 0.3090245130616695 } }, { "accn": "0001193125-26-072519", "filed": "2026-02-26", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 50000.0, "cash": 188657000.0, "eps_diluted": -0.37, "free_cash_flow": 16652000.0, "net_income": -61286000.0, "operating_cash_flow": 16702000.0, "operating_income": -73379000.0, "revenue": 726437000.0, "stockholders_equity": 431755000.0, "total_assets": 748956000.0, "total_liabilities": 317201000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.73467823186761, "net_margin": -0.08436519615603282, "operating_margin": -0.10101220064506626, "revenue_growth_yoy": 0.4044621883669899, "roa_avg2y": -0.0916927993488773, "roa_period_end": -0.08182857203894488, "roe_avg2y": -0.1472923736553196, "roe_period_end": -0.14194624266076825 } }, { "accn": "0001193125-26-072519", "filed": "2026-02-26", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 0.0, "cash": 114846000.0, "eps_diluted": -1.34, "free_cash_flow": -114035000.0, "net_income": -215975000.0, "operating_cash_flow": -114035000.0, "operating_income": -223596000.0, "revenue": 517235000.0, "stockholders_equity": 400413000.0, "total_assets": 587812000.0, "total_liabilities": 187399000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.46801427526079326, "net_margin": -0.4175568165340706, "operating_margin": -0.43229093158815624, "revenue_growth_yoy": 0.06834729264992925, "roa_avg2y": -0.33538209256064366, "roa_period_end": -0.3674218967969351, "roe_avg2y": -0.4588832336315357, "roe_period_end": -0.5393805895412986 } }, { "accn": "0000950170-25-029253", "filed": "2025-02-27", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1122000.0, "cash": 147435000.0, "eps_diluted": -1.05, "free_cash_flow": -126782000.0, "net_income": -167870000.0, "operating_cash_flow": -125660000.0, "operating_income": -170439000.0, "revenue": 484145000.0, "stockholders_equity": 540894000.0, "total_assets": 700122000.0, "total_liabilities": 159228000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.2943793053722171, "net_margin": -0.3467349657643888, "operating_margin": -0.3520412273182621, "revenue_growth_yoy": 0.0959581668571946, "roa_avg2y": -0.22643245131641598, "roa_period_end": -0.239772496793416, "roe_avg2y": -0.287472504137758, "roe_period_end": -0.310356557846824 } }, { "accn": "0000950170-24-021473", "filed": "2024-02-28", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 7587000.0, "cash": 326028000.0, "eps_diluted": -1.79, "free_cash_flow": -143753000.0, "net_income": -281584000.0, "operating_cash_flow": -136166000.0, "operating_income": -286586000.0, "revenue": 441755000.0, "stockholders_equity": 627009000.0, "total_assets": 782616000.0, "total_liabilities": 155607000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.2481734711941934, "net_margin": -0.6374211950062818, "operating_margin": -0.6487442134214666, "revenue_growth_yoy": 0.30282001675140674, "roa_avg2y": -0.35966813109473184, "roa_period_end": -0.3597984196591943, "roe_avg2y": -0.42466579798272286, "roe_period_end": -0.44909084239620173 } }, { "accn": "0001564590-21-008372", "filed": "2023-02-28", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1129000.0, "cash": 189680000.0, "free_cash_flow": -152259000.0, "net_income": -235259000.0, "operating_cash_flow": -151130000.0, "operating_income": -246545000.0, "revenue": 339076000.0, "stockholders_equity": 699135000.0, "total_assets": 783183000.0, "total_liabilities": 84048000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.12021712544787487, "net_margin": -0.6938238035130767, "operating_margin": -0.7271083768830586, "revenue_growth_yoy": 0.5150375099974531, "roa_avg2y": -0.35554128239325666, "roa_period_end": -0.30038828728407024, "roe_avg2y": -0.39934850544977396, "roe_period_end": -0.33650010369957156 } }, { "accn": "0001564590-21-008372", "filed": "2022-03-01", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2104000.0, "cash": 134758000.0, "free_cash_flow": -169574000.0, "net_income": -245192000.0, "operating_cash_flow": -167470000.0, "operating_income": -247444000.0, "revenue": 223807000.0, "stockholders_equity": 479079000.0, "total_assets": 540202000.0, "total_liabilities": 61123000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.12758438587372856, "net_margin": -1.0955510774908739, "operating_margin": -1.1056133186182737, "revenue_growth_yoy": 0.7918751651307836, "roa_avg2y": -0.5303122715495053, "roa_period_end": -0.45388947097567206, "roe_avg2y": -0.6021680722625263, "roe_period_end": -0.5117986803846547 } }, { "accn": "0001564590-21-008372", "filed": "2021-02-25", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 812000.0, "cash": 69418000.0, "free_cash_flow": -218569000.0, "net_income": -289403000.0, "operating_cash_flow": -217757000.0, "operating_income": -292410000.0, "revenue": 124901000.0, "stockholders_equity": 335285000.0, "total_assets": 384506000.0, "total_liabilities": 49221000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.14680346570827804, "revenue_growth_yoy": 6.206797068836189, "roa_avg2y": -0.6120662945099661, "roa_period_end": -0.75266185703214, "roe_avg2y": -0.6780001311942424, "roe_period_end": -0.8631552261508866 } }, { "accn": "0001564590-20-006889", "filed": "2020-02-27", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1506000.0, "cash": 163620000.0, "free_cash_flow": -209914000.0, "net_income": -271393000.0, "operating_cash_flow": -208408000.0, "operating_income": -272815000.0, "revenue": 17331000.0, "stockholders_equity": 518411000.0, "total_assets": 561153000.0, "total_liabilities": 42742000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.0824480962016624, "roa_period_end": -0.48363458807134596, "roe_period_end": -0.5235093391151037 } }, { "accn": "0001193125-13-103111", "filed": "2013-03-12", "fiscal_year": 2012, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares" }, "fundamentals": { "eps_diluted": -0.38 }, "period_end": "2012-12-31", "ratios": {} }, { "accn": "0001193125-13-103111", "filed": "2013-03-12", "fiscal_year": 2011, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares" }, "fundamentals": { "eps_diluted": -0.44 }, "period_end": "2011-12-31", "ratios": {} }, { "accn": "0001193125-13-103111", "filed": "2013-03-12", "fiscal_year": 2010, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares" }, "fundamentals": { "eps_diluted": 0.39 }, "period_end": "2010-12-31", "ratios": {} }, { "accn": "0001193125-12-098990", "filed": "2012-03-06", "fiscal_year": 2009, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares" }, "fundamentals": { "eps_diluted": -1.2 }, "period_end": "2009-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001193125-26-072519", "filed": "2026-02-26", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001070494.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001070494.json" }, "ticker": "ACAD" }